Natera Inc (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as panorama prenatal testing, pre-implantation genetic testing, miscarriage testing, genetic carrier screening and paternity testing. Its pre-implantation genetic testing includes translocation testing, aneuploidy screening, and single gene testing. Natera offers constellation, a cloud-based software product that allows laboratory customers to gain access through the cloud to the companys algorithms and bioinformatics in order to validate and launch tests. The company also undertakes clinical trial of several genetic materials. Natera is headquartered in San Carlos, California, the US.

Natera Inc (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Natera Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Natera Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Natera Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Natera Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Natera Inc, Medical Devices Deals, 2012 to YTD 2018 9
Natera Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Natera Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Natera Raises USD55.5 Million in Venture Financing 11
Natera Raises US$54.6 Million In Venture Financing 13
Partnerships 15
Natera Enters into Research Agreement with Neon Therapeutics 15
Natera Enters into Agreement with Imperial College London and University of Leicester 16
Natera Enters into Research Agreement with University of California, San Francisco 17
Equity Offering 18
Natera Prices Public Offering of Shares for USD90 Million 18
Natera Raises USD180 Million in IPO 20
Natera Inc - Key Competitors 22
Natera Inc - Key Employees 23
Natera Inc - Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Strategy And Business Planning 25
Jan 04, 2017: Leading Genetic Testing Companies Join Forces to Launch the Coalition for Access to Prenatal Screening 25
Financial Announcements 26
Aug 08, 2018: Natera reports second quarter 2018 financial results 26
May 08, 2018: Natera Reports First Quarter 2018 Financial Results 28
Mar 13, 2018: Natera Announces Fourth Quarter And Fiscal Year 2017 Financial Results 30
Nov 08, 2017: Natera Reports Third Quarter 2017 Financial Results 32
Aug 08, 2017: Natera Reports Second Quarter 2017 Financial Results 34
May 09, 2017: Natera Reports First Quarter 2017 Financial Results 36
Mar 07, 2017: Natera Reports Fourth Quarter and Fiscal Year 2016 Financial Results 38
Corporate Communications 40
Jul 31, 2018: Natera appoints Roy Baynes to Board of Directors adding deep oncology experience 40
Apr 09, 2018: Natera Appoints Paul R. Billings, M.D., Ph.D., as Chief Medical Officer 41
May 04, 2017: Natera Announces the Appointment of Gail Marcus as Member of the Board of Directors 42
Feb 03, 2017: Natera Announces Appointment of Mike Brophy as New Chief Financial Officer 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List Of Tables


Natera Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Natera Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Natera Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Natera Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Natera Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Natera Inc, Medical Devices Deals, 2012 to YTD 2018 9
Natera Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Natera Raises USD55.5 Million in Venture Financing 11
Natera Raises US$54.6 Million In Venture Financing 13
Natera Enters into Research Agreement with Neon Therapeutics 15
Natera Enters into Agreement with Imperial College London and University of Leicester 16
Natera Enters into Research Agreement with University of California, San Francisco 17
Natera Prices Public Offering of Shares for USD90 Million 18
Natera Raises USD180 Million in IPO 20
Natera Inc, Key Competitors 22
Natera Inc, Key Employees 23
Natera Inc, Subsidiaries 24

List Of Figures


Natera Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Natera Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Natera Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Natera Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Natera Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Natera Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Natera Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Natera Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Natera Inc, Medical Devices Deals, 2012 to YTD 2018 9

Natera Inc (NTRA) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as

USD 250 View Report

Natera Inc (NTRA) - Product Pipeline Analysis, 2018 Update

Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as

USD 750 View Report

Natera Inc (NTRA) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as

USD 250 View Report

Natera Inc (NTRA) - Product Pipeline Analysis, 2018 Update

Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as

USD 750 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available